HK1140940A1 - Titration of tapentadol - Google Patents

Titration of tapentadol

Info

Publication number
HK1140940A1
HK1140940A1 HK10107329.5A HK10107329A HK1140940A1 HK 1140940 A1 HK1140940 A1 HK 1140940A1 HK 10107329 A HK10107329 A HK 10107329A HK 1140940 A1 HK1140940 A1 HK 1140940A1
Authority
HK
Hong Kong
Prior art keywords
tapentadol
titration
administration
unitbcontaining
unitacontaining
Prior art date
Application number
HK10107329.5A
Other languages
English (en)
Inventor
Claudia Lange
Ferdinand Rombout
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1140940(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of HK1140940A1 publication Critical patent/HK1140940A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesive Tapes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK10107329.5A 2007-04-23 2010-08-02 Titration of tapentadol HK1140940A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (fr) 2007-04-23 2007-04-23 Titrage de tapentadol
PCT/EP2008/003178 WO2008128740A1 (fr) 2007-04-23 2008-04-21 Titration du tapentadol

Publications (1)

Publication Number Publication Date
HK1140940A1 true HK1140940A1 (en) 2010-10-29

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10107329.5A HK1140940A1 (en) 2007-04-23 2010-08-02 Titration of tapentadol

Country Status (22)

Country Link
US (4) US20090012180A1 (fr)
EP (5) EP1985292A1 (fr)
JP (4) JP5933176B2 (fr)
KR (3) KR20150027840A (fr)
CN (1) CN101730530B (fr)
AT (1) ATE534378T1 (fr)
AU (1) AU2008241013B2 (fr)
CA (1) CA2683786C (fr)
CY (1) CY1112320T1 (fr)
DK (1) DK2148670T3 (fr)
ES (1) ES2378255T3 (fr)
HK (1) HK1140940A1 (fr)
HR (1) HRP20120147T1 (fr)
IL (1) IL201479A (fr)
MX (1) MX2009011444A (fr)
NZ (1) NZ580415A (fr)
PL (1) PL2148670T3 (fr)
PT (1) PT2148670E (fr)
RU (1) RU2472497C2 (fr)
SI (1) SI2148670T1 (fr)
WO (1) WO2008128740A1 (fr)
ZA (1) ZA200907355B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (fr) * 2007-04-23 2008-10-29 Grünenthal GmbH Titrage de tapentadol
CN104257600A (zh) * 2008-10-30 2015-01-07 格吕伦塔尔有限公司 新型有效的他喷他多剂型
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) * 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US20130116333A1 (en) * 2010-05-05 2013-05-09 Ratiopharm Gmbh Solid tapentadol in non-crystalline form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
ES2591354T3 (es) * 2010-06-30 2016-11-28 Grünenthal GmbH Tapentadol para su uso en el tratamiento del síndrome de intestino irritable
MX341072B (es) * 2010-07-23 2016-08-05 Grünenthal Gmbh * Sales o co-cristales de 3-(3-dimetilamino-1-etil-2-metil-propil)-f enol.
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
DK2680833T3 (en) * 2011-03-04 2016-05-23 Gruenenthal Gmbh PARENTERAL SUBMISSION OF TAPENTADOL
PT2680834T (pt) 2011-03-04 2018-01-25 Gruenenthal Gmbh Composição farmacêutica aquosa semissólida contendo tapentadol
CN103501773A (zh) 2011-03-04 2014-01-08 格吕伦塔尔有限公司 用于口服给予的他喷他多含水药物制剂
WO2012136351A1 (fr) * 2011-04-05 2012-10-11 Grünenthal GmbH Tapentadol utilisé dans le traitement de la douleur associée à une névralgie faciale
JP2014510759A (ja) 2011-04-05 2014-05-01 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 疼痛の慢性化を予防するためのタペンタドール
ES2788548T3 (es) 2011-04-29 2020-10-21 Gruenenthal Gmbh Tapentadol para la prevención y el tratamiento de la depresión y la ansiedad
EP2968182B8 (fr) * 2013-03-15 2018-07-25 SpecGx LLC Forme galénique solide dissuasive d'abus pour libération immédiate avec marque fonctionnelle
EP2845625A1 (fr) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol pour utilisation dans le traitement de la fibromyalgie et du syndrome de fatigue chronique
SI3273953T1 (sl) 2015-03-27 2019-03-29 Gruenenthal Gmbh Stabilna oblika za parenteralno dovajanje tapentadola
PT3302454T (pt) * 2015-05-26 2021-04-01 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Composições para utilização no tratamento da doença de parkinson e distúrbios associados
MX2018010367A (es) * 2016-02-29 2018-12-10 Guenenthal Gmbh Titulacion de cebranopadol.
EA201990744A1 (ru) 2016-09-23 2019-08-30 Грюненталь Гмбх Стабильная лекарственная форма для парентерального введения тапентадола
AU2021237693A1 (en) 2020-03-16 2022-09-08 Grünenthal GmbH Scored tablet
BR112023018841A2 (pt) * 2021-03-17 2023-12-26 Actelion Pharmaceuticals Ltd Sistema de dosagem farmacêutica
WO2022234076A1 (fr) * 2021-05-07 2022-11-10 Grünenthal GmbH Tapentadol utilisé dans le traitement de la douleur neuropathique chez des patients âgés

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
PT1572167E (pt) 2002-12-13 2008-10-03 Euro Celtique Sa Regime posológico de buprenorfina papa analgesia
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
EP1985292A1 (fr) * 2007-04-23 2008-10-29 Grünenthal GmbH Titrage de tapentadol
DE102007019417A1 (de) * 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose

Also Published As

Publication number Publication date
US20170079938A1 (en) 2017-03-23
KR20150027840A (ko) 2015-03-12
ZA200907355B (en) 2010-08-25
PL2148670T3 (pl) 2012-04-30
US20090012180A1 (en) 2009-01-08
CY1112320T1 (el) 2015-12-09
US11344512B2 (en) 2022-05-31
JP2018030864A (ja) 2018-03-01
RU2472497C2 (ru) 2013-01-20
US20160074342A1 (en) 2016-03-17
JP2016128468A (ja) 2016-07-14
US20190290603A1 (en) 2019-09-26
HRP20120147T1 (hr) 2012-03-31
EP2148670A1 (fr) 2010-02-03
JP2010531296A (ja) 2010-09-24
CA2683786C (fr) 2021-10-26
WO2008128740A8 (fr) 2010-06-17
EP2422778A1 (fr) 2012-02-29
ATE534378T1 (de) 2011-12-15
KR102078999B1 (ko) 2020-02-19
CA2683786A1 (fr) 2008-10-30
AU2008241013A1 (en) 2008-10-30
EP3603630A1 (fr) 2020-02-05
ES2378255T3 (es) 2012-04-10
DK2148670T3 (da) 2012-03-12
MX2009011444A (es) 2009-11-05
PT2148670E (pt) 2012-01-24
IL201479A (en) 2016-04-21
CN101730530A (zh) 2010-06-09
RU2009142940A (ru) 2011-05-27
IL201479A0 (en) 2010-05-31
JP2019131598A (ja) 2019-08-08
EP2148670B1 (fr) 2011-11-23
NZ580415A (en) 2012-04-27
KR20100017267A (ko) 2010-02-16
SI2148670T1 (sl) 2012-03-30
KR20180004839A (ko) 2018-01-12
EP3143993A1 (fr) 2017-03-22
CN101730530B (zh) 2013-10-23
EP1985292A1 (fr) 2008-10-29
JP5933176B2 (ja) 2016-06-08
AU2008241013B2 (en) 2013-06-20
WO2008128740A1 (fr) 2008-10-30

Similar Documents

Publication Publication Date Title
HK1140940A1 (en) Titration of tapentadol
HK1148202A1 (en) Pharmaceutical solutions, process of preparation and therapeutic uses
HK1129594A1 (en) Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
MY153408A (en) Novel methods
WO2010014690A3 (fr) Dispositifs médicaux permettant l'administration d'un agent thérapeutique
IN2012DN01435A (fr)
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
CY1115455T1 (el) Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας
MX2014004862A (es) Formulaciones de polimero acrilico.
WO2008087186A3 (fr) Nouveaux peptides pour le traitement de l'obésité
WO2011026125A3 (fr) Compositions pharmaceutiques à rétention gastrique permettant une libération immédiate et prolongée d'acétaminophène
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
WO2008087188A3 (fr) Nouveaux peptides pour le traitement de l'obésité
EP2073819A4 (fr) Formulations topiques contenant le co-enzyme q10 et traitement de la douleur, de la fatigue et des plaies
MY150931A (en) Substituted oxazolidinones and their use
WO2012100043A3 (fr) Formes posologiques pharmaceutiques orales à libération contrôlée comprenant de la mgbg
MX2009011999A (es) Extruidos con enmascaramiento del sabor mejorado.
MX2009008108A (es) Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno.
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
WO2007135123A3 (fr) Mirtazapine utilisée pour le traitement de la douleur neuropathique
EA201000738A1 (ru) Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата
UA99093C2 (ru) Применение фенофибрата или его производного для лечения диабетической ретинопатии
UA47310U (ru) Полифункциональное средство для внешнего применения

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210417